Dr. Simon Sumer explains how AI‑driven protein design is shortening development cycles, improving screening efficiency, and ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...

Modern medicine has played a significant role in improving the length and quality of our lives. While many treatments may ...

Domestic researchers have made significant progress toward developing artificial intelligence (AI)-based antibody drugs that ...

Orthogon Therapeutics today announced the closing of a follow-on $11 million financing, bringing its total capital raised to $36 million. This financing supports the continued advancement of its first ...

The rapid advances in machine learning (ML) and artificial intelligence (AI) are transforming biology and opening new directions for scientific inquiry.

Fathom Therapeutics, formerly Atommap Corp., a company that uses quantum chemistry and AI to design novel drug molecules by ...

Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...

TOKYO, April 21, 2026 /CNW/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million 1) in five R&D projects for the ...

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...